XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.20.2

Business Segments | 9 Months Ended
--- | ---
Sep. 30, 2020
Business Segments [Abstract] |
Business Segments | Note 13 Business Segments: The Company has organized its business into two operating segments to present its organization based upon the Company’s management structure, products and services offered, markets served and types of customers, as follows: The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Management reviews financial information presented on an operating segment basis for the purposes of making certain operating decisions and assessing financial performance. Unallocated operating expenses include costs that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. Interest expense and other income (expense), net, are also not allocated to the operating segments. The following tables reflect results of operations from our business segments for the periods indicated below: Three Months Ended September 30, 2020
|  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | TOTAL |
Revenues |  | $ | 3,835 |  |  | $ | 1,778 |  |  | $ | 5,613 |
Costs of revenues |  |  | 1,368 |  |  |  | 1,015 |  |  |  | 2,383 |
Gross profit |  |  | 2,467 |  |  |  | 763 |  |  |  | 3,230 |
Gross profit % |  |  | 64.3 | % |  |  | 42.9 | % |  |  | 57.5 | %
Allocated operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 329 |  |  |  | 82 |  |  |  | 411 |
Selling and marketing |  |  | 1,883 |  |  |  | 168 |  |  |  | 2,051 |
Unallocated operating expenses |  |  | - |  |  |  | - |  |  |  | 1,929 |
|  |  | 2,212 |  |  |  | 250 |  |  |  | 4,391 |
Income (loss) from operations |  |  | 255 |  |  |  | 513 |  |  |  | (1,161 | )
Interest expense, net |  |  | - |  |  |  | - |  |  |  | (21 | )
Income (loss) before income taxes |  | $ | 255 |  |  | $ | 513 |  |  | $ | (1,182 | )
Nine Months Ended September 30, 2020
|  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | TOTAL |
Revenues |  | $ | 12,332 |  |  | $ | 4,041 |  |  | $ | 16,373 |
Costs of revenues |  |  | 4,534 |  |  |  | 2,246 |  |  |  | 6,780 |
Gross profit |  |  | 7,798 |  |  |  | 1,795 |  |  |  | 9,593 |
Gross profit % |  |  | 63.2 | % |  |  | 44.4 | % |  |  | 58.6 | %
Allocated operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 828 |  |  |  | 122 |  |  |  | 950 |
Selling and marketing |  |  | 6,021 |  |  |  | 425 |  |  |  | 6,446 |
Unallocated operating expenses |  |  | - |  |  |  | - |  |  |  | 5,921 |
|  |  | 6,849 |  |  |  | 547 |  |  |  | 13,317 |
Income (loss) from operations |  |  | 949 |  |  |  | 1,248 |  |  |  | (3,724 | )
Interest expense, net |  |  | - |  |  |  | - |  |  |  | (38 | )
Income (loss) before income taxes |  | $ | 949 |  |  | $ | 1,248 |  |  | $ | (3,762 | )
Three Months Ended September 30, 2019
|  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | TOTAL |
Revenues |  | $ | 5,991 |  |  | $ | 1,489 |  |  | $ | 7,480 |
Costs of revenues |  |  | 1,966 |  |  |  | 889 |  |  |  | 2,855 |
Gross profit |  |  | 4,025 |  |  |  | 600 |  |  |  | 4,625 |
Gross profit % |  |  | 67.2 | % |  |  | 40.3 | % |  |  | 61.8 | %
Allocated operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 226 |  |  |  | 23 |  |  |  | 249 |
Selling and marketing |  |  | 2,762 |  |  |  | 125 |  |  |  | 2,887 |
Unallocated operating expenses |  |  | - |  |  |  | - |  |  |  | 2,218 |
|  |  | 2,988 |  |  |  | 148 |  |  |  | 5,354 |
Income (loss) from operations |  |  | 1,037 |  |  |  | 452 |  |  |  | (729 | )
Interest expense, net |  |  | - |  |  |  | - |  |  |  | (153 | )
Income (loss) before income taxes |  | $ | 1,037 |  |  | $ | 452 |  |  | $ | (882 | )
Nine Months Ended September 30, 2019
|  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | TOTAL |
Revenues |  | $ | 17,142 |  |  | $ | 5,546 |  |  | $ | 22,688 |
Costs of revenues |  |  | 5,492 |  |  |  | 3,052 |  |  |  | 8,544 |
Gross profit |  |  | 11,650 |  |  |  | 2,494 |  |  |  | 14,144 |
Gross profit % |  |  | 68.0 | % |  |  | 45.0 | % |  |  | 62.3 | %
Allocated operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 666 |  |  |  | 122 |  |  |  | 788 |
Selling and marketing |  |  | 8,301 |  |  |  | 610 |  |  |  | 8,911 |
Unallocated operating expenses |  |  | - |  |  |  | - |  |  |  | 7,398 |
|  |  | 8,967 |  |  |  | 732 |  |  |  | 17,097 |
Income (loss) from operations |  |  | 2,683 |  |  |  | 1,762 |  |  |  | (2,953 | )
Interest expense, net |  |  | - |  |  |  | - |  |  |  | (433 | )
Income (loss) before income taxes |  | $ | 2,683 |  |  | $ | 1,762 |  |  | $ | (3,386 | )

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration